← Leaderboards
Jessica L Rouge
University Of Connecticut Storrs
$2,000,300
Attributed
$2,000,300
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.5K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,000,300 · 1
By mechanism
R35$2,000,300 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- James F. Rusling$10,459,986
- Amy R. Howell$5,587,235
- Xiang-Qun Xie$8,062,308
- Carolyn M Teschke$8,060,107
- Alexandros Makriyannis$48,379,340
Others in their field
Other Emerging Leaders on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$77,392,336
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Anthony Philippakis · University Of California Santa Cruz$41,478,771
Research focus
VisionTreatment EfficacyUnited States Food And Drug AdministrationUptakeAchievementCatalytic DnaCellsChargeClinical ApplicationClinical TrialsCytosolDesignDisease PathwayEndocytosisEventFutureGenesGene SilencingHydrophobicityInnovationIn VitroKnock-DownMessenger RnaMolecular
Grant awards (5)
Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates$402,500
R35 · FY2024 · GM · contact PI
Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates$402,500
R35 · FY2023 · GM · contact PI
Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates$402,500
R35 · FY2022 · GM · contact PI
Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates$402,500
R35 · FY2021 · GM · contact PI
Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates$390,300
R35 · FY2020 · GM · contact PI